Pregnancy-associated stroke outcomes; a robotic device for shoulder movement in ALS; non-invasive neurostimulation for refractory seizures.
In this week's podcast, Neurology Today's editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.
2 Maalis 20235min
Acute infections and increased risk for dementia, alternatives to CPAP for sleep apnea; the legacy of Dr. Ralph Sacco.
In this week's podcast, Neurology Today's editor-in-chief discusses the associated risk between acute infections and dementia; alternative therapies to CPAP for sleep apnea; and Dr. Ralph Sacco's impact on the field.
16 Helmi 20235min
IV thrombolysis for large vessel occlusion; impact of mindfulness, exercise on cognition;new brain layer in subarachnoid space.
In this week's podcast, Neurology Today's editor-in-chief discusses the report on outcomes of IV thrombolysis for large vessel occlusions; the discovery of a new brain layer in the subarachnoid space; and the impact of mindfulness and exercise on cognition.
2 Helmi 20235min
Best advances of 2022, misdiagnosed autoimmune encephalitis, inflation his neurology private practice
In this week's podcast, Neurology Today's editor-in-chief discusses the report on misdiagnosis of autoimmune encephalitis, inflationary times for neurologists in private practice, and the editorial board picks for best advances in 2022.
19 Tammi 20235min
Spinal cord stimulation for chronic pain, disparities in brain age by race/ethnicity, careers in teleneurology
In this week's podcast, Neurology Today's editor-in-chief discusses a comparison of spinal cord stimulation with medical management for chronic pain, earlier brain aging in Black people, and the pros/cons of working for teleneurology companies.
4 Tammi 20235min
Rituximab for MS, food security and cognition, in utero treatment for Pompe disease
In this week's podcast, Neurology Today's editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.
15 Joulu 20225min
Modifiable risk factors for monogenic stroke, health care systems prepare for wave of new Alzheimer's therapies, criteria for selecting neurology residents
In this week's podcast, Neurology Today's editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer's therapies, and criteria program directors apply in selecting neurology residents.
1 Joulu 20225min
Revascular therapies for stroke patients with COVID, dementia and suicide risk, hyperbaric oxygen therapy for concussion in children.
In this week's podcast, Neurology Today's editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion.
17 Marras 20225min
